MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2015 |
Branche |
Arzneimittelhersteller |
Börse |
NASDAQ GLOBALSPB |
Anteile |
42.7 M |
Marktkapitalisierung |
$ 55.5 M |
EBITDA (LTM) |
$ -36.6 M |
P/E (LTM) |
- |
P/S (LTM) |
162.2 |
EPS (LTM) |
-0.86 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.21 | 1.68 % | $ 130 M | Nasdaq Global Select Market |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Cronos Group
CRON
|
$ 2.67 | 0.19 % | $ 1.39 B | Nasdaq Global Market | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Aurora Cannabis
ACB
|
$ 4.35 | -3.12 % | $ 86.3 M | NYSE | Canada |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Emergent BioSolutions
EBS
|
$ 12.29 | -1.09 % | $ 629 M | NYSE,SPB | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.57 | -0.12 % | $ 2.05 B | Nasdaq Global Select Market |  France |
 |
Evolus
EOLS
|
$ 6.66 | -3.55 % | $ 413 M | Nasdaq Global Market | USA |
 |
Harrow Health
HROW
|
$ 50.7 | 1.22 % | $ 1.65 B | Nasdaq Global Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 1.27 | -1.32 % | $ 22.2 M | NYSE American |  China |
 |
OrganiGram Holdings
OGI
|
$ 1.7 | -5.31 % | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 5.19 | -1.71 % | $ 683 M | Nasdaq Capital Market | USA |
 |
Bausch Health Companies
BHC
|
$ 7.16 | -0.56 % | $ 2.61 B | NYSE | Canada |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.66 | 0.83 % | $ 4.54 M | Nasdaq Capital Market | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.01 | -2.55 % | $ 56.4 M | Nasdaq Global Select Market | USA |
 |
Rockwell Medical
RMTI
|
$ 0.8 | -7.01 % | $ 18.7 M | Nasdaq Global Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 26.17 | -1.3 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Sundial Growers
SNDL
|
$ 1.71 | -1.16 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Veru
VERU
|
$ 2.22 | -7.71 % | $ 299 M | Nasdaq Capital Market | USA |
 |
Perrigo Company plc
PRGO
|
$ 13.94 | 0.87 % | $ 1.92 B | NYSE | USA |
 |
ProPhase Labs
PRPH
|
$ 0.45 | -14.17 % | $ 7.13 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
cbdMD
YCBD
|
$ 1.43 | -15.88 % | $ 6.17 M | NYSE American | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.43 | -1.77 % | $ 133 M | Nasdaq Global Select Market,SPB | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Assertio Holdings
ASRT
|
$ 9.56 | -3.82 % | $ 679 M | Nasdaq Capital Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Solid Biosciences
SLDB
|
$ 5.63 | -3.68 % | $ 230 M | Nasdaq Global Select Market,SPB | USA |
 |
SCYNEXIS
SCYX
|
$ 0.63 | 6.75 % | $ 30.1 M | Nasdaq Global Select Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Tilray
TLRY
|
$ 9.32 | -2.87 % | $ 5.76 B | Nasdaq Global Select Market | Canada |
 |
TherapeuticsMD
TXMD
|
$ 1.68 | -3.43 % | $ 17.5 M | Nasdaq Global Select Market | USA |